FINDING COMFORT & PURPOSE ON LOW-ENERGY DAYS
A Gentle, Resource-Rich Handbook for Aspergillosis, Asthma, Bronchiectasis & COPD Patients
Many people living with aspergillosis (ABPA/CPA), asthma, bronchiectasis and COPD experience unpredictable energy levels, breathlessness, coughing, pain, flare-ups, treatment effects and fatigue.
On these days, large tasks feel impossible — but gentle activities can still offer comfort, focus, pleasure and calm.
This handbook brings together low-energy, low-breathing-demand hobbies and micro-activities, with recommended resources for every ability and symptom level.
Table of Contents
- 1. Understanding Fluctuating Energy
- 2. Creative Hobbies (with resources)
- 3. Music, Singing & Breath-Friendly Voice Work
- 4. Gentle Movement
- 5. Quiet Mind–Body Practices
- 6. Low-Effort Cognitive Hobbies (Puzzles & Jigsaws)
- 7. Social Connection (Low-Energy Options)
- 8. Good / Medium / Bad Day Plans
- 9. When Rest Is the Right Choice
- 10. Final Thoughts
1. Understanding Fluctuating Energy & Breathlessness
Living with lung disease means your available energy changes daily. You may move between:
-
Good days (stable breathing, clearer head)
-
Medium days (ok but fragile)
-
Bad days (breathless, fatigued, flaring, coughing)
This is normal.
Helpful Resources
-
The Spoon Theory by Christine Miserandino
-
The Energy Envelope approach – ME Association
-
NHS Lothian – “Managing Breathlessness”
-
NAC Facebook Community – patient-to-patient pacing strategies
2. Creative Hobbies (All low-energy & breath-friendly)
Creativity calms the mind without increasing breathlessness. Most activities below can be done sitting or reclining.
🎨 Watercolour Painting
Why it helps: slow movements, calming colours, short bursts (5–10 min), easy to pause.
Beginner Tutorials (YouTube)
-
Sarah Burns Studio – gentle landscapes
-
Steven Cronin – skies & mist
-
Watercolor Misfit – textures, blending
-
Liron Yanconsky – excellent for beginners
Materials
-
100% cotton paper: Etchr, Saunders Waterford, Arches
-
Paints: Winsor & Newton Cotman, Daniel Smith
-
Brushes: Da Vinci / Escoda size 6–8 round + 1" flat
✏️ Drawing & Colouring
Resources
-
Colouring apps: Lake, Pigment, Happy Color
-
Colouring books: Johanna Basford, Millie Marotta
-
Drawing tutorials: Draw With Shiba, Art for Kids Hub
Materials
-
Staedtler Noris pencils
-
Faber-Castell Polychromos
-
Smooth sketchpad
-
Sakura Micron pens
💻 Digital Art
Apps
-
Procreate / Procreate Pocket
-
Ibis Paint X
-
Sketchbook (free)
Tutorials
-
Bardot Brush (digital watercolour)
-
Stayf Draws
-
Genevieve’s Design Studio
🧵 Crafts (very low breath demand)
Knitting, crochet, loom bands, origami, scrapbooking.
Tutorials
-
Bella Coco Crochet
-
VeryPink Knits
-
Jo Nakashima (origami)
Beginner Kits
-
Hobbycraft
-
Etsy
-
The Works
📝 Writing, Journalling, Story Snippets
Apps
-
Day One
-
Penzu
-
Bear Notes
-
Gratitude App
Prompt Sources
-
Pinterest: “Journal prompts chronic illness”
-
Reddit r/Journaling
3. Music, Singing & Breath-Friendly Voice Work
Music is deeply calming and very compatible with breathlessness.
🎧 Listening to Music
Playlists (Spotify)
-
Peaceful Piano
-
Lo-Fi Beats
-
Deep Focus
-
Calming Acoustic
-
Rain Sounds / Ocean Waves
YouTube Channels
-
Ambient World
-
Nature Healing Society
-
Lofi Girl
🎤 Gentle Singing (VERY breath-friendly)
Guided Sessions
-
Singing for Lung Health – British Lung Foundation
-
Sidcot Singing for Breathing (YouTube)
-
Breath-Supported Vocal Warmups – Carolyn Grace Music
Why it's helpful
-
controls exhale
-
relaxes throat
-
reduces panic around breathlessness
😌 Humming
One of the most effective breathing tools:
-
lengthens exhale
-
improves nasal airflow
-
calms upper airway
-
reduces anxiety
🎶 Breathing With Music
Apps:
-
Calm
-
Breathing Zone
-
Insight Timer: “Breathing With Music” tracks
🎹 Easy Instruments
-
Kalimba
-
Tongue/Handpan drum
-
Small keyboard
-
Tablet piano apps: FlowKey, Simply Piano, Yousician
🫁 Singing for Lung Health Groups
Available through:
-
British Lung Foundation
-
Local NHS respiratory teams
-
Online Zoom groups (search “singing for breathing UK”)
-
NAC Facebook events
4. Gentle Movement (Breath-aware & low strain)
🪑 Chair-Based Stretching
Videos
-
NHS Sitting Exercises
-
BLF Chair Exercises
-
Jenny Wren Chair Yoga
-
HasFit Senior Chair Workouts
🛏️ Bed-Based Mini Yoga
Videos
-
Yoga With Adriene (Gentle series, Bedtime)
-
Gentle Yoga for Chronic Illness
-
Sleepy Slow Stretching
🏥 Pulmonary Rehab Mini Exercises
-
NHS PR worksheets
-
BLF Pulmonary Rehab Home Sessions
-
“Living Well With Breathlessness” (NHS Ayrshire)
🥋 Seated Tai Chi / Qigong
Videos
-
Dr Paul Lam – Tai Chi for Health
-
Qigong With Mimi Kuo-Deemer
-
Tai Chi for Seniors (seated)
5. Quiet Mind–Body Practices
🫁 Breathing Techniques
Resources
-
NHS Breathlessness Support
-
BLF Breathing Control
-
4-7-8 Breathing (guided)
-
Apps: Breathe2Relax, Breathing Zone, Oak
🧘 Guided Relaxation
Apps
-
Calm
-
Headspace
-
Insight Timer
-
Aura
YouTube
-
Michael Sealey
-
The Honest Guys
-
Guided Sleep Meditation channels
🌿 Sensory Grounding
Tools:
-
lavender/chamomile inhaler stick
-
warm mug
-
textured blanket
-
grounding cards (“5-4-3-2-1”)
**6. Low-Effort Cognitive Hobbies
(DAILY PUZZLES, JIGSAWS & BRAIN GAMES)**
Cognitive activities are perfect for breathless or fatigued days because they require almost no physical energy.
🧩 Daily Puzzle Sites
New York Times Games
-
Wordle
-
Connections
-
Mini Crossword
-
Spelling Bee
-
Letter Boxed
Others
-
Guardian Puzzles
-
Telegraph Puzzles
-
BBC Puzzle Hub
-
Washington Post Crosswords
-
AARP Games (gentle)
📱 Puzzle Apps (by energy level)
Very Low Energy
-
Zen Match
-
Tiles
-
Color Sort
-
Simple digital jigsaws
-
Solitaire
Medium Energy
-
Flow Free
-
Nonograms (easy mode)
-
Wordscapes
-
Easy Sudoku
-
NYT Mini Crossword
High Energy
-
NYT Crossword
-
Good Sudoku
-
Lumosity
-
Elevate
-
Brilliant.org
🧠 Tiny “Brain Snacks” (1–2 minutes)
-
Brainful
-
Left vs Right
-
Peak (1-minute games)
-
Picture matching
-
Memory card apps
🧩 Jigsaws
Digital Jigsaws
-
Ravensburger Puzzle App
-
Microsoft Jigsaw
-
Magic Jigsaw
-
Jigidy
Physical Jigsaws
-
100–500 pieces (fatigue-friendly)
-
1000+ pieces for long-term projects
-
Use a puzzle roll mat
⭐ Puzzle Difficulty Ladder
(To match breathing & fatigue level)
Level 1 — very low energy / flare
Matching games, colour sort, easy jigsaws, Wordle
Level 2 — low energy, stable
Word searches, Flow Free, easy Sudoku, Mini Crossword
Level 3 — medium
Connections, Spelling Bee, medium Sudoku, trivia
Level 4 — good day
Cryptic crosswords, hard Sudoku, logic puzzles, Brilliant.org
7. Social Connection (without exhaustion)
Low-Effort Options
-
WhatsApp voice notes
-
NAC Facebook & Telegram groups
-
“Photo-a-day” messages
-
5-minute video chats
-
Online craft or puzzle groups
Apps
-
Telegram
-
WhatsApp
-
Discord “chill lounge” servers
-
Facebook Messenger Lite
8. Good / Medium / Bad Day Plans
Good Day
-
1 creative hobby
-
1 gentle movement
-
some music
-
small social contact
Medium Day
-
1 light creative or cognitive activity
-
breathing practice
-
sensory grounding
Bad Day
-
full rest
-
breathing support
-
soft music
-
low-sensory comfort
9. When Rest Is the Right Choice
Good rest-day resources
-
Calm Sleep Stories
-
BBC Sounds (audiobooks, drama)
-
Bob Ross – The Joy of Painting
-
Nature documentaries (slow paced)
-
Gentle ASMR channels
-
Ambient rain / ocean playlists
10. Final Thoughts
Your worth is not measured by productivity.
On low-energy days, you deserve calm, comfort, connection and kindness toward yourself.
This handbook gives you choices — not obligations.
Pick whatever feels gentle today, and leave the rest for tomorrow.
ABPA or Bronchiectasis? A Detailed Guide to Understanding Flare-Ups
Many people with allergic bronchopulmonary aspergillosis (ABPA) also live with bronchiectasis, and the symptoms can overlap so much that it’s difficult to know what’s flaring. This guide explains what is happening inside the lungs, the typical signs of each condition, and how to judge when to seek help.
1. What exactly happens during an ABPA flare?
ABPA is an allergic immune reaction to Aspergillus in the airways.
The fungus is usually present in tiny amounts, but the immune system over-reacts to it.
During a flare:
-
The immune system releases large amounts of inflammatory chemicals (especially IgE and eosinophils).
-
Airways become swollen, narrow and sticky.
-
Thick, glue-like mucus forms and can block off airway sections.
Typical symptoms of an ABPA flare
-
Increased wheeze, chest tightness or asthma-like symptoms
-
Shortness of breath, sometimes sudden
-
Very thick, sticky, tenacious sputum
-
Mucus plugs — sometimes shaped like soft tubes or “casts” of an airway
-
Drop in peak flow or lung function
-
IgE levels rising (but this may lag behind symptoms by days or weeks)
Colour of mucus in ABPA
-
Often golden-brown
-
Can be brown or even dark brown if old mucus is clearing
-
May contain small black dots (fungal elements) but this can also appear in bronchiectasis
2. What happens during a bronchiectasis flare?
Bronchiectasis is a structural lung condition. The airways are wider and more damaged, meaning mucus gets trapped more easily.
During a flare:
-
The airway lining becomes irritated or infected.
-
Mucus production increases.
-
Trapped mucus becomes a breeding ground for bacteria.
-
Breathing may be heavier simply because of mucus load.
Typical symptoms of a bronchiectasis flare
-
Increase in sputum volume
-
Change in sputum colour (yellow, green, brown)
-
Worsening cough
-
Feeling more tired, feverish, or run down
-
Chest tightness from mucus but not usually dramatic wheeze
-
No immediate change in IgE levels
Bronchiectasis and brown sputum
-
Brown sputum is common when old blood, dried mucus or debris is being cleared.
-
After a lung bleed, blood changes colour as it ages:
-
Fresh = bright red
-
24–48 hours = dark red
-
After a few days = brown, tar-like, sticky
-
This often appears suddenly after you think everything has settled.
3. Comparing the two conditions side-by-side
| Feature | ABPA Flare | Bronchiectasis Flare |
|---|---|---|
| Main cause | Immune/allergic reaction to Aspergillus | Infection, inflammation, mucus trapping |
| Breathing | Sudden ↑ wheeze + breathlessness | Heavy/chesty breathing, fatigue |
| Mucus amount | Normal amount but very thick or plug-like | More mucus than usual |
| Mucus colour | Golden-brown, brown, plug-like | Yellow, green, brown |
| Mucus plugs | Common | Possible but less typical |
| IgE | Often rises (but may lag) | Stable |
| Peak flow | Drops significantly | Mild change or no change |
| General wellbeing | Often feel “inflamed” without infection symptoms | More infection-like tiredness/malaise |
4. Understanding brown sputum properly
Brown sputum doesn’t always mean ABPA.
It can be:
-
Old blood breaking loose
-
Dried mucus from bronchiectasis
-
A mixture of dried secretions and oxidised blood proteins
-
Debris from a recently cleared airway infection
This is why a single brown plug — especially after a bleed — is rarely a sign of ABPA on its own.
5. When you should ask for help
Contact your specialist if you notice any of these:
-
Several days of brown plugs or repeated mucus casts
-
Dramatically increased wheeze
-
Peak flow drop >20% from your baseline
-
Fever, chills, or sudden tiredness
-
Breathlessness that feels “different” from normal
-
A major change in your usual bronchiectasis pattern
-
New chest pain
Seek urgent help if:
-
You cough up fresh bright red blood
-
You feel suddenly very breathless
-
You cough up a large amount of blood-stained sputum
-
You have signs of severe infection (rigors, high fever, confusion)
6. And what about IgE?
IgE is helpful, but has limitations:
-
It rises slowly — sometimes days or weeks after symptoms appear.
-
It can stay stable at your “baseline” even when mild inflammation is happening.
-
A stable IgE level is reassuring, but it does not rule out a flare.
Think of IgE as a trend, not an immediate alarm light.
7. The real-world takeaway
-
Bronchiectasis = more mucus, infected/inflamed feeling, colour change.
-
ABPA = allergic response, wheeze, plugs, sudden breathing changes.
-
Brown sputum alone is not enough to diagnose either way.
-
After a bleed, brown sputum is expected for days as the airway clears.
Learning your own pattern takes time. Even experienced patients still contact their team if something feels wrong — and that’s always the safest approach.
⚠️ Flu Season Warning: UK Flu Cases Are Now Surging — Dominated by a Drifted H3N2 Strain
The UK flu season has begun much earlier and much faster than usual, and cases are now surging across the country. The UK Health Security Agency (UKHSA) confirms that the dominant strain this year is a drifted influenza A(H3N2) variant (sub-clade K). This strain now accounts for the vast majority of flu cases in people tested.
🔥 Why this flu season is different
-
Almost all flu cases are influenza A, and around 84% of typed cases are H3N2.
This pattern is consistent across community, GP and hospital surveillance. -
The H3N2 strain circulating is genetically drifted, meaning it has evolved away somewhat from the reference vaccine strain.
UKHSA has publicly confirmed this drift. -
This increases the risk of infection spreading rapidly — which is exactly what is happening now.
🛡️ Does the flu vaccine still work?
Yes — despite the drift, UKHSA reports that the 2025–26 flu vaccine still provides important protection, including:
-
~70–75% effectiveness in children
-
~30–40% effectiveness in adults
This means vaccination dramatically reduces severity, even if it does not fully prevent infection.
⚠️ Why this matters for people with lung conditions
If you have:
-
ABPA (Allergic Bronchopulmonary Aspergillosis)
-
Bronchiectasis
-
Asthma
-
Chronic lung disease
…you are at higher risk of: -
pneumonia
-
severe chest infections
-
hospitalisation
-
long recovery times
H3N2 seasons are historically worse for adults and people with underlying respiratory disease.
🔺 What you should do now
1. Get vaccinated immediately
If you haven’t had your flu jab yet, do not wait.
The season is already surging and accelerating earlier than usual.
2. Be extremely cautious in high-risk environments
-
Schools
-
Public transport
-
Healthcare settings
-
Large indoor gatherings
-
Poorly ventilated rooms
3. Use winter protection behaviours
-
Ventilate indoor spaces
-
Consider wearing a mask in crowded indoor areas
-
Wash hands frequently
-
Avoid contact with people who are unwell
4. If you become ill — act fast
For anyone with ABPA, bronchiectasis or asthma:
-
A sudden fever
-
A sharp rise in cough
-
Change in sputum
-
Chest tightness
-
Breathing changes
…should be treated as early warning signs.
Contact your GP or respiratory team quickly, as secondary pneumonia is more likely in H3N2 seasons.
Summary
Flu is now surging across the UK, driven by a drifted H3N2 strain, and people with underlying lung disease should take this season particularly seriously.
Vaccination remains strongly protective, but additional precautions are vital during this rapid upswing in cases.
Why Exposure to Young Children Can Increase Illness in Aspergillosis, ABPA, and Bronchiectasis — and How to Track Viral Outbreaks
Many patients with Allergic Bronchopulmonary Aspergillosis (ABPA), aspergillus-related asthma, or bronchiectasis notice that they become ill far more often when spending time around younger children. This applies whether you work with them, live with them, or spend time with grandchildren or family groups. Here’s why it happens, what other patients experience, and how to monitor viral outbreaks so you can protect yourself.
Why Young Children Increase Illness Risk
1. Young children spread far more respiratory infections
Children under 11:
-
Carry more colds, viruses, and respiratory bugs
-
Shed viruses for longer periods
-
Have high viral loads
-
Are still learning hygiene habits
-
Spend a lot of time in close physical contact with adults
Even small viral infections can cause major lung flares in ABPA and bronchiectasis.
2. Viral infections trigger flare-ups, exacerbations, and pneumonia
With:
-
Bronchiectasis → mucus doesn’t clear properly, so infections “stick”
-
ABPA → airways are inflamed, reactive, and mucus-filled
-
Asthma → viruses are the most common exacerbation trigger
A simple cold in a child can turn into:
-
Fever
-
Chest infection
-
Need for antibiotics
-
Pneumonia
-
Weeks of recovery
This pattern is extremely common.
3. Children spread viruses even when only mildly ill
Some viruses (RSV, adenovirus, flu) spread before symptoms, or for many days after a child appears well.
Adults with lung conditions may experience far more severe symptoms from these same infections.
4. Any indoor, close-contact time increases risk
This includes:
-
Teaching music or classroom work
-
Caring for grandchildren
-
Sitting in cars together
-
Birthday parties, playgroups, soft play
-
Family gatherings
-
Living in the same household
Even short exposures can be enough in winter months.
What Other Aspergillosis Patients Report
Across support groups and clinics:
-
Many patients stay well until grandchildren reach nursery/school age.
-
Switching from high school to primary/elementary teaching often leads to repeated infections.
-
People frequently report more pneumonias in winter when around young children.
This is very common and not your fault.
How to Reduce Risk (Realistically)
1. Improve ventilation
-
Open windows/doors during visits or lessons
-
Use a HEPA air purifier at home or work
-
Avoid long stays in small rooms
2. Control exposure without avoiding children
Shorter visits with good ventilation are safer than long indoor contact.
3. Keep up with airway clearance routines
Vital for preventing infections from settling.
4. Mask during periods of high virus circulation
Especially when RSV, flu, COVID, or “winter bugs” are rising.
5. Stay vaccinated
Flu, pneumococcal, COVID (if eligible), and pertussis if around infants.
6. Get medical review if you're repeatedly unwell
Your team may consider:
-
Prophylactic antibiotics
-
Nebulised saline
-
Optimising inhalers/biologics
-
Checking ABPA control
7. Use Occupational Health if exposure is workplace-related
Ask for:
-
Teaching older groups
-
Ventilation improvements
-
Reduced winter exposure
Where to Get Reliable Information on Viral Outbreaks
Tracking viral activity can help you plan safer weeks and reduce the chance of flare-ups.
1. UK Health Security Agency (UKHSA)
Weekly reports on:
-
Flu
-
COVID
-
RSV
-
Measles and other outbreaks
-
Regional activity levels
Best official national overview. Link
2. GOV.UK Infectious Disease Reports
Lists:
-
Confirmed outbreaks
-
Public health warnings
-
School/nursery clusters
-
Localised alerts
3. Local NHS Trust or ICB Websites
Many publish:
-
Weekly respiratory dashboards
-
Local flu/RSV alerts
-
Outbreak notices for schools and care settings
(Example: Greater Manchester ICB has regular respiratory activity updates.)
4. GP Surgeries & NHS App Alerts
GPs can push:
-
Local viral alerts
-
Flu surges
-
Measles/strep notifications
Often one of the earliest local signals.
5. School/Nursery Letters and Newsletters
Schools must notify families about:
-
Flu/strep outbreaks
-
High absence levels
-
Confirmed clusters
Very useful if you work with or spend time around children.
6. Zoe Health Study App
Crowd-sourced, real-time data on:
-
Colds
-
Flu-like illness
-
COVID
-
Regional spikes
Good for early warning.
7. Local Council Public Health
Check:
[Your council] + “Public Health”
They often post:
-
Local outbreak alerts
-
Enhanced infection-control notices
-
Community virus trends
8. NHS 111 Online Data
Shows real-time spikes in:
-
Cough
-
Fever
-
Chest infections
-
Sore throat or strep symptoms
A useful snapshot of local trends.
Key Message
Yes — any exposure to young children can raise infection risk when you have aspergillosis, ABPA, or bronchiectasis.
Tracking viral outbreaks helps you plan safer contact, adjust your activities, and reduce the chance of pneumonia or flare-ups.
Resources
Here are direct links to trusted resources you can use to monitor viral outbreaks and infection risk (especially helpful for those with ABPA, bronchiectasis, asthma, and other lung conditions):
-
UK Health Security Agency (UKHSA) “Influenza and Respiratory Viruses” dashboard — UK data on influenza, RSV, COVID-19, ICU/hospital admission rates.
https://ukhsa-dashboard.data.gov.uk/ -
UKHSA / GOV.UK “National flu and COVID-19 surveillance reports” — weekly/bi-weekly reports summarising community, primary care, hospital and mortality data.
https://www.gov.uk/government/statistics/national-flu-and-covid-19-surveillance-reports-2025-to-2026-season -
GOV.UK “Outbreaks under monitoring” — current outbreaks of various infectious diseases in the UK.
https://www.gov.uk/government/publications/outbreaks-under-monitoring-in-2025/outbreaks-under-monitoring-week-41-week-ending-12-october-2025 -
GOV.UK “Infectious diseases: detailed information” — data, guidance, and analysis for a wide range of infections (flu, RSV, scarlet-fever, etc.).
https://www.gov.uk/government/collections/infectious-diseases-detailed-information -
Public Health Wales “Weekly influenza and acute respiratory infection report” — regional data including GP consultations and infection trends.
https://www.phw.nhs.wales/topics/immunisation-and-vaccines/fluvaccine/weekly-influenza-and-acute-respiratory-infection-report/ -
GOV.UK “Prepare – infectious disease outbreaks” — advice for the public on how to stay prepared for outbreaks, with hygiene and vaccination guidance.
https://prepare.campaign.gov.uk/be-informed-about-hazards/health-infectious-disease-outbreaks/
Understanding Risk from Aspergillosis — and What’s Improving
🧫 How risky is aspergillosis?
The outlook for people with aspergillosis has improved dramatically in the past two decades.
Two things have changed that make a huge difference:
-
We diagnose it earlier.
Better scans, blood tests (like galactomannan and PCR), and greater awareness mean the infection or allergic reaction is recognised much sooner. -
We treat it better.
Modern antifungal medicines, steroid-sparing biologics, and specialist clinics have all transformed care and monitoring.
⚖️ Risk of death — managed vs. unmanaged
| Type of Aspergillosis | If well managed | If unmanaged or poorly treated |
|---|---|---|
| Allergic (ABPA) | Survival > 95 % | About 90 % (may progress to chronic lung damage) |
| Chronic (CPA) | 5-year survival ≈ 80–90 % | 5-year survival ≈ 50 % |
| Invasive (IA) | 5-year survival ≈ 50–70 % | < 20 % (often fatal if untreated) |
Across all forms of aspergillosis, the risk of death has fallen by roughly 50 % since the early 2000s.
💊 What’s driven this improvement
-
New antifungal drugs — triazoles (itraconazole, voriconazole, posaconazole, isavuconazole) now form the backbone of long-term therapy.
-
Rapid diagnosis — galactomannan, PCR, and CT scanning detect infection days earlier than before.
-
Improved hospital and ICU care — faster recognition and better ventilation strategies save lives in invasive cases.
-
Specialist clinics and monitoring — regular blood tests, imaging, and drug-level checks prevent deterioration and drug toxicity.
-
Biologic therapies — agents that target allergic inflammation (like anti-IgE or anti-IL-5 biologics) help reduce steroid use and preserve lung function.
🚀 What could make outcomes even better
Researchers and clinicians are optimistic about the next decade.
Future advances are already on the horizon:
| Future area | How it helps |
|---|---|
| Next-generation antifungals – Olorofim, Fosmanogepix | Active against azole-resistant strains and safer for long-term use |
| Combination or personalised therapy | Matching the right drug and dose to each patient’s response pattern |
| Routine antifungal-resistance testing | Prevents treatment failure by identifying resistant Aspergillus early |
| Rapid home or bedside testing | Detects infection flare-ups before symptoms become severe |
| Improved imaging and AI-supported analysis | Spots fungal cavities or airway changes at an earlier, reversible stage |
| Global stewardship of agricultural azoles | Reduces environmental resistance by limiting unnecessary fungicide use |
| Patient self-monitoring and digital follow-up | Enables early reporting of symptoms and better long-term adherence |
⚠️ Potential barriers to further progress
Even with all these advances, several important challenges could slow improvement if left unaddressed:
| Barrier | Why it matters |
|---|---|
| Antifungal resistance | Aspergillus fumigatus is developing resistance to azoles used both in medicine and agriculture. Resistant strains can make first-line treatment fail unless resistance testing is done. |
| Delayed or missed diagnosis | Symptoms often mimic other lung conditions. Late recognition allows infection or inflammation to cause irreversible damage. |
| Limited access to specialist care | Some regions lack experienced clinicians, diagnostic testing, or antifungal drug availability, increasing global inequality in outcomes. |
| Drug toxicity and interactions | Long-term antifungal therapy can affect the liver or interfere with other medicines if not closely monitored. |
| Environmental change | Warmer, wetter climates and increased composting or construction may raise Aspergillus exposure for vulnerable people. |
| Healthcare strain and cost | Long-term follow-up, monitoring, and expensive new drugs may challenge already stretched healthcare systems. |
Each of these barriers needs attention through research, public health policy, and education to ensure the gains of the last 20 years continue.
❤️ The key message
Aspergillosis is still a serious disease, but its outlook is far better than it used to be.
With modern antifungals, biologics, and regular monitoring, most people live many years — and new treatments promise even better results.
Patients can help by:
-
Reporting new symptoms early.
-
Keeping up with regular blood and imaging checks.
-
Asking about resistance testing and treatment options.
-
Staying informed about new drugs and trials.
🌅 A hopeful future
In just twenty years, deaths from aspergillosis have halved.
If we continue improving diagnosis, drug development, and resistance control, survival will rise even higher — turning aspergillosis from a life-threatening infection into a long-term but manageable condition for most people.
Aspergillosis & Asthma: When Risks Peak Through the Year
Many people living with aspergillosis, asthma, or bronchiectasis notice that their symptoms change with the seasons.
This is no coincidence — environmental factors such as temperature, humidity, pollen, spores, and viral infections all vary through the year, and these can strongly influence both lung health and allergic or fungal disease.
Understanding these patterns can help you plan ahead, reduce exposure, and know when to take extra care.
🌸 Spring: Pollen and Early Spore Season
As temperatures rise, tree pollen (especially birch, oak, and plane) and Aspergillus spores begin to increase in outdoor air.
For people with Allergic Bronchopulmonary Aspergillosis (ABPA) or Severe Asthma with Fungal Sensitisation (SAFS), this can trigger cough, wheeze, and chest tightness.
-
Keep an eye on Met Office pollen and spore forecasts.
-
Open windows on dry days, but check for signs of mould indoors, especially around windows and bathrooms.
-
If you notice symptoms flaring every spring, let your respiratory team know — small medication adjustments may help.
📊 Data source: Met Office spore count data.
☀️ Summer: Soil, Compost, and Renovation Hazards
Warm, humid conditions mean fungi thrive — especially outdoors.
Compost heaps, garden soil, and grass cuttings can release very high levels of Aspergillus spores.
People with chronic lung disease, ABPA, or Chronic Pulmonary Aspergillosis (CPA) are at greater risk of exacerbations during this period.
-
If gardening or using compost, wear gloves and an FFP2/FFP3 mask.
-
Avoid turning compost heaps or cleaning bird feeders if you are immunocompromised.
-
Keep home humidity below 60% and ventilate well during warm spells.
🪴 Source: Protective mask and compost safety advice.
🍂 Autumn: Damp Homes and Viral Load
As the weather cools, we close windows and turn on heating — trapping moisture indoors.
This increases damp and mould growth, particularly in poorly ventilated areas.
At the same time, colds, flu, and RSV infections surge, all of which can make fungal or allergic conditions worse.
-
Use a dehumidifier and ensure air can circulate behind furniture.
-
Check for leaks, condensation, or cold corners.
-
Stay up to date with flu and COVID vaccinations if eligible.
💧 Source: Aspergillosis.org damp guidance.
❄️ Winter: Indoor Season and Medication Review
Outdoor spore levels are lowest in winter, but indoor exposure dominates — from bathrooms, humidifiers, and heating systems.
Viral infections remain a major trigger for asthma and ABPA flare-ups, and antifungal or steroid treatments may need review.
-
Keep homes warm but ventilated where possible.
-
Review your treatment plan with your clinical team, especially if you’re using steroids or biologics.
-
Contact your GP or specialist early if you notice an increase in cough, breathlessness, or mucus plugs.
🧭 Key Takeaway
Aspergillosis and asthma flare-ups often follow the seasons:
| Season | Main Risks | Take Action |
|---|---|---|
| Spring | Pollen, outdoor spores | Monitor counts, check home for mould |
| Summer | Compost, soil, renovation dust | Use masks/gloves, avoid heavy exposure |
| Autumn | Damp homes, viruses | Dehumidify, ventilate, manage infections |
| Winter | Indoor air, viruses | Keep warm, review treatment |
By spotting your personal pattern, you and your care team can plan ahead — reducing exacerbations and staying well all year.
🫁 Understanding Chronic Cough in Aspergillosis
What the latest British Thoracic Society statement means for you
🌬️ Why This Matters
If you live with aspergillosis, Allergic Bronchopulmonary Aspergillosis (ABPA), or bronchiectasis, coughing can dominate your life. It’s tiring, painful, and socially awkward — especially when people assume it means infection.
Doctors used to see cough as just a symptom of another problem, but the British Thoracic Society (BTS) Clinical Statement on Chronic Cough in Adults (2023) recognises something new:
For many people, a cough can become a condition in its own right — caused by airway and nerve hypersensitivity, not just infection.
This matters for aspergillosis patients because fungal allergy and inflammation make the airways especially sensitive.
💡 What Is “Chronic Cough”?
A chronic cough is one lasting eight weeks or more.
It may be:
-
Dry – little or no mucus
-
Productive – thick sputum (common in bronchiectasis or chronic aspergillosis)
-
Triggered by dust, cold air, perfume, or strong scents
For people with aspergillosis, several overlapping causes may exist:
-
Fungal colonisation or infection
-
Allergic inflammation (ABPA)
-
Bronchiectasis and mucus retention
-
Reflux or post-nasal drip
-
Nerve hypersensitivity
This is why one treatment rarely fixes everything — different “treatable traits” must be addressed together.
🧬 Why It Happens
1️⃣ The Hypersensitive Cough Reflex
People with aspergillosis often develop overactive airway nerves — so normal irritants like dust, scent, or cold air trigger coughing fits.
This “cough reflex hypersensitivity” happens because:
-
Ongoing inflammation damages the airway lining.
-
Nerve endings in the throat and lungs become over-responsive.
-
Even mild triggers set off powerful reflexes.
This is a real physiological process, not psychological.
It’s why cough can continue even when infection is under control.
2️⃣ Treatable Traits – Finding the Real Drivers
| Treatable Trait | What It Means | What Helps |
|---|---|---|
| Airway infection or colonisation | Persistent fungi or bacteria | Antifungal or antibiotic therapy, sputum tests |
| Allergic inflammation | ABPA or asthma-type airway swelling | Corticosteroids, biologics (e.g., mepolizumab, benralizumab) |
| Cough reflex hypersensitivity | Overactive airway nerves | Speech therapy, nerve-modulating medication |
| Airway clearance problems | Mucus that’s hard to shift | Physiotherapy, saline or mucolytic therapy |
| Reflux or postnasal drip | Acid or sinus drainage irritation | Reflux management, ENT care |
Identifying these traits helps your clinician personalise treatment.
💊 Medications That Can Cause or Worsen Cough
The BTS statement highlights that some medicines can trigger or amplify chronic cough — especially in people with already-sensitive lungs.
🔹 ACE Inhibitors (Blood pressure or heart disease)
Examples: Ramipril, Lisinopril, Enalapril, Perindopril
-
Can cause a dry, tickly cough due to bradykinin build-up.
-
Happens in ~1 in 5 users, sometimes months after starting.
-
GP can switch to a similar drug (ARB – e.g., losartan) that doesn’t cause cough.
🔹 Beta Blockers (Heart or migraine medicines)
Examples: Atenolol, Propranolol, Bisoprolol
-
May tighten airways, worsening wheeze or cough.
-
Safer “lung-selective” versions exist but should still be monitored.
🔹 Inhalers
Examples: Fluticasone, Budesonide, Salbutamol
-
Can irritate the throat if used without a spacer or if technique is poor.
-
Always rinse or gargle after use, and ask your pharmacist to review inhaler technique.
🔹 Antifungal or Reflux Medicines
-
Antifungals (itraconazole, voriconazole) don’t directly cause cough, but reflux or nausea can trigger coughing indirectly.
-
PPIs (omeprazole, lansoprazole) usually help reflux-related cough, but long-term use should be reviewed regularly.
🔹 Other Drugs
-
Amiodarone, methotrexate, and some biologics can rarely cause cough due to lung inflammation.
-
Nasal sprays or lozenges with menthol/alcohol may irritate already-sensitive airways.
💬 If you suspect a medicine is contributing, don’t stop it suddenly — speak to your doctor or pharmacist first.
They can review interactions using the
👉 BNF Interactions Checker – NICE Medicines Guidance.
🔍 How Doctors Assess Chronic Cough
BTS recommends a structured pathway:
-
Basic tests: chest X-ray, spirometry, bloods (eosinophils, IgE), FeNO if available.
-
Further tests: CT scan, allergy or sputum studies if initial tests are abnormal.
-
Trait-based review: identifying overlapping issues — fungal, allergic, nerve-related, or reflux-related.
-
Specialist referral: to a Cough Clinic or Aspergillosis Centre if symptoms persist.
🧴 Pharmacists: Your Safety Specialists
Pharmacists — hospital or community — are crucial for managing long-term cough and medication safety:
-
Check for cough-inducing drugs or interactions.
-
Advise on best timing for antifungal and steroid doses.
-
Help switch to fragrance-free personal or cleaning products.
-
Liaise with your GP and consultant to fine-tune treatment.
🧭 Regular medication reviews every few months can prevent small problems becoming major triggers.
💬 How It Feels — and Why It’s Misunderstood
People with aspergillosis often describe:
“A tickle that turns into a spasm I can’t stop.”
“People think I’m ill, but it’s just the air or perfume.”
This happens because your airway nerves and immune cells are already primed.
Coughing doesn’t mean you’re infectious — it’s your body’s protective reflex in overdrive.
🩺 What Helps Most
-
Optimise your aspergillosis and ABPA treatment.
-
Cough-control physiotherapy or speech therapy for nerve-related cough.
-
Airway clearance techniques for mucus.
-
Identify and avoid irritants: perfume, smoke, strong detergents, cold air.
-
Ask about biologics if inflammation remains active despite steroids.
-
Use nerve-modulating medicines only under specialist advice.
🧘 Emotional Health Matters Too
Living with a chronic cough can cause anxiety, embarrassment, and isolation.
Support from counsellors, CBT therapists, or patient groups helps manage this stress — and can actually reduce cough frequency through better relaxation and breathing control.
🌱 Key Takeaway
Chronic cough in aspergillosis isn’t “just a symptom” — it’s often a mix of airway inflammation, fungal allergy, nerve hypersensitivity, and sometimes side effects of medicines.
The good news is that every contributing factor is treatable once identified — and cough can improve significantly with the right combination of medical, physical, and environmental care.
🔗 Trusted Resources
🩺 Article 1: Managing Side Effects of Aspergillosis Treatments
Subtitle: What to expect, how to recognise problems early, and when to ask for help.
💊 Why This Matters
People living with aspergillosis, bronchiectasis, or Primary Ciliary Dyskinesia (PCD) often take several medicines for months or even years.
These drugs are vital for controlling infection, inflammation, and allergic reactions — but they can also cause side effects or drug interactions.
Being aware of what’s normal, what’s not, and when to seek help helps you stay safe while getting the most from treatment.
⚗️ Antifungal Medicines
Antifungal (azole) drugs are the backbone of treatment for Chronic Pulmonary Aspergillosis (CPA) and Allergic Bronchopulmonary Aspergillosis (ABPA).
They control infection but can affect the liver, heart, or skin, so regular blood monitoring is essential.
Itraconazole (Sporanox® / generic)
Used for long-term control in CPA and ABPA.
-
Common: tiredness, nausea, ankle swelling, blurred vision.
-
Serious: yellowing skin/eyes, dark urine, shortness of breath.
-
Tips:
-
Take with a main meal or fizzy drink (acidic stomach aids absorption).
-
Avoid taking it with omeprazole or similar acid-reducing drugs, as these block absorption.
-
Have regular liver-function and drug-level blood tests.
-
Report ankle swelling or jaundice immediately.
-
Voriconazole (Vfend®)
Used when itraconazole isn’t effective or tolerated.
-
Common: temporary visual flashes or blurred vision, sunlight sensitivity, mild headache.
-
Serious: severe rash, blistering, or long-term skin-cancer risk from sunlight.
-
Tips:
-
Always use SPF 30+ sun cream, even in winter.
-
Avoid prolonged sun exposure.
-
Report any visual change, rash, or fatigue promptly.
-
Blood monitoring checks for safe drug levels.
-
Posaconazole (Noxafil®)
Used for resistant infections or as a second-line therapy.
-
Common: nausea, diarrhoea, fatigue.
-
Serious: liver inflammation, low potassium (causing muscle cramps or irregular heartbeat).
-
Tips:
-
Take with a main meal or full-fat snack.
-
Report unexplained muscle weakness or palpitations.
-
Keep up with blood tests.
-
Isavuconazole (Cresemba®)
A newer antifungal option that may cause fewer interactions.
-
Common: headache, mild nausea, ankle swelling.
-
Tips:
-
Continue regular liver and kidney checks.
-
Report any new swelling, fatigue, or breathlessness.
-
💨 Corticosteroids
(Prednisolone, Methylprednisolone, Hydrocortisone)
These reduce inflammation and allergic response in ABPA and asthma.
They are powerful — but long-term use can affect weight, mood, bones, and hormone balance.
-
Common: increased appetite, fluid retention, mood swings, difficulty sleeping.
-
Long-term: thinning bones, higher blood sugar, adrenal suppression.
-
Tips:
-
Never stop suddenly — always taper under medical advice.
-
Carry a Steroid Emergency Card.
-
Ask about bone protection (vitamin D, calcium, bisphosphonates).
-
See your GP if you feel very tired, dizzy, or unwell.
-
🧬 Biologic Treatments
(Mepolizumab, Benralizumab, Omalizumab)
These injection-based medicines target inflammation or allergic responses in severe asthma or ABPA.
-
Common: mild injection-site soreness, tiredness, headache.
-
Occasional: mild fever or muscle aches.
-
Serious: allergic swelling of lips, tongue, or throat.
-
Tips:
-
Record any mild reactions.
-
If you develop swelling or difficulty breathing, call 999 immediately.
-
💊 Long-Term Antibiotics
(Azithromycin, inhaled colomycin, tobramycin)
Used to reduce bacterial infections in bronchiectasis or PCD.
-
Common: stomach upset, diarrhoea, mild throat irritation.
-
Long-term: tinnitus or hearing loss (especially with azithromycin).
-
Tips:
-
Have periodic hearing checks.
-
Rinse mouth and nebuliser after inhaled antibiotics.
-
Report ringing in the ears, severe diarrhoea, or rash.
-
⚠️ Drug Interactions
Antifungal medicines (especially azoles) can interfere with many common drugs, including:
-
Steroids (e.g., prednisolone, fluticasone) — may increase steroid levels.
-
Reflux medicines (e.g., omeprazole, lansoprazole) — reduce antifungal absorption.
-
Statins and warfarin — increase risk of side effects or bleeding.
-
Some antihistamines and antibiotics — can affect heart rhythm.
These interactions can be complex — always check before starting or stopping any medication.
✅ Check it yourself:
You can use the official BNF Interactions Checker (NICE Medicines Guidance) to see if two medicines are known to interact.
Simply type the names (e.g., itraconazole and prednisolone) and it will show the risk level, what the interaction does, and what clinicians usually recommend.
If unsure, show the result to your GP, pharmacist, or hospital team — they can interpret it for your situation.
🚨 When to Seek Help
Call your specialist or GP urgently if you notice:
-
Yellowing of skin or eyes
-
Severe rash, blistering, or peeling
-
New ankle swelling or breathlessness
-
Sudden fatigue or dark urine
-
Visual changes or increased photosensitivity
-
Ringing in the ears or hearing loss
If you feel acutely unwell, do not stop your medication abruptly — contact your hospital team or emergency services.
🔗 Next read: Why Awareness Matters – Staying Safe and Confident on Aspergillosis Treatment »
⚠️ Omeprazole and PPIs: What’s Behind the Recent Warning?
Recently, several newspapers – including The Mirror – reported that a “BBC doctor” had issued a warning to anyone taking omeprazole, a commonly prescribed drug for acid reflux and heartburn.
So, is this something new, or just another media scare? Let’s look at what the evidence actually says – and what it means if you’re living with aspergillosis, bronchiectasis, or other chronic lung diseases.
💊 What Are PPIs?
Proton Pump Inhibitors (PPIs) such as omeprazole, lansoprazole, and esomeprazole are medicines that reduce stomach acid.
They’re often used to:
-
Treat reflux, indigestion, or stomach ulcers
-
Protect the stomach from irritation caused by anti-inflammatory drugs or steroids
They’re very effective and widely prescribed — millions of people in the UK take them every day.
⚠️ Why the Headlines?
The recent news stories stem from a discussion on BBC Morning Live, where GP Dr Punam Krishan highlighted the potential long-term side effects of PPIs.
Although these aren’t “new discoveries”, they serve as an important reminder that long-term PPI use should be reviewed regularly.
🧠 What the Evidence Shows
Research over the past decade has shown that taking PPIs for a long time or at high doses can lead to several possible side effects:
| Possible Issue | What Happens | Why It Matters |
|---|---|---|
| Infections | Higher risk of gut infections such as Clostridioides difficile and bacterial overgrowth | Stomach acid normally helps kill harmful bacteria; reducing it alters the balance |
| Changes in gut microbiome | Loss of protective “friendly” bacteria | May influence digestion, immunity, and inflammation |
| Reduced absorption of nutrients | Low magnesium, iron, or vitamin B12 | Can lead to tiredness, cramps, or anaemia |
| Bone health | Slightly higher risk of fractures with very long-term use | May relate to calcium absorption |
| Kidney and heart effects (rare) | Observed in some studies | Still being researched |
Most of these risks are small, and for many people the benefits outweigh them — but it’s still important to make sure you’re taking the lowest effective dose and that your doctor reviews the need for it periodically.
🫁 Why It Matters for Aspergillosis and Lung Conditions
If you have aspergillosis, bronchiectasis, or Primary Ciliary Dyskinesia (PCD), there are extra reasons to think carefully about long-term PPI use:
-
Microbiome connections: The gut and lungs are linked through what’s called the gut–lung axis. Disturbances in gut bacteria can affect immune responses elsewhere in the body — possibly including the lungs.
-
Infection control: PPIs can slightly increase the risk of bacterial or fungal overgrowth in the gut. While this doesn’t directly cause lung infection, it may influence the body’s balance between helpful and harmful microbes.
-
Medication interactions: Some antifungal medicines (like itraconazole or posaconazole) rely on stomach acidity for absorption — so PPIs can reduce their effectiveness. Your specialist will usually time doses or adjust medication accordingly.
-
Reflux and aspiration: On the other hand, reflux itself can worsen lung disease if acid is inhaled into the lungs — so stopping PPIs suddenly can make things worse. Always discuss any change with your doctor first.
🩺 What You Can Do
If you take omeprazole or another PPI:
-
Check why you’re on it – Is it for reflux, ulcer protection, or another reason?
-
Review the dose and duration – Many people can step down to a lower dose or switch to on-demand use once symptoms are controlled.
-
Don’t stop suddenly – Stopping PPIs abruptly can cause a rebound in acid production and make symptoms flare.
-
Ask about alternatives – Some people can switch to H2-blockers (e.g. ranitidine-type medicines), or use lifestyle changes such as avoiding late meals, raising the bedhead, and reducing caffeine or alcohol.
-
Discuss with your specialist team – Particularly if you’re also on antifungal or antibiotic treatments, as interactions can occur.
🧩 Key Takeaway
The recent headlines about omeprazole are not new, but they highlight a genuine issue:
PPIs are very useful drugs — but long-term use should always be reviewed to make sure the benefits outweigh the risks.
For most people, there’s no need to panic.
Just make sure you:
-
Use the lowest effective dose
-
Review your need for PPIs at least once a year
-
Discuss any concerns with your respiratory or gastroenterology team
🔗 Useful References
-
NHS Guidance: Proton Pump Inhibitors – Risks and Review Advice
-
PrescQIPP PPI Safety Review (UK 2023) – Long-term safety and deprescribing guidance
-
Gut (BMJ): Proton pump inhibitors and gut microbiota: cause for concern? (Gut 2016;65:740–748)
🧬 Article 2: When Microbes Turn Hostile – The Evolutionary Pressures Behind Infection
Subtitle: Why stable colonisation sometimes shifts into active disease
Introduction
If microbes can live quietly in the lungs for years, why do they sometimes turn aggressive?
Evolutionary biology and microbiome research show that infection often develops because of environmental pressures — not by design, but as a by-product of survival in a changing ecosystem.
1. Antibiotic Pressure
Repeated antibiotic courses kill sensitive strains and leave behind resistant survivors.
These survivors often produce thicker biofilms and inflammatory molecules, which protect them but also damage airway tissue.
Over time, this selection creates harder-to-treat, more inflammatory strains.
2. Nutrient Competition
Airways are crowded ecosystems.
When nutrients run low, microbes compete by releasing toxins, proteases, and iron-scavenging molecules.
These harm competitors — and incidentally harm the lung.
3. Biofilms and Mutation
Within biofilms, bacteria and fungi evolve quickly.
Mutations can accumulate, producing hypermutator strains that are well adapted to chronic survival but also more inflammatory.
4. Host Factors
Changes in the body — reduced immunity, steroid use, diabetes, or viral infections — relax immune control.
Organisms that were previously contained can now proliferate.
Similarly, damaged or scarred airways provide sheltered niches where microbes thrive.
5. Microbiome Collapse
The healthy lung microbiome helps regulate inflammation and suppress invaders.
When broad antibiotics or infections reduce diversity, opportunists like Pseudomonas or Aspergillus can expand unchecked.
6. Collateral Damage, Not Intent
Most microbes don’t “want” to be pathogenic — they’re simply adapting to survive.
Their survival strategies (biofilms, enzymes, toxins) cause collateral damage to airway tissue.
So, pathogenicity is often an accidental consequence of survival pressure.
7. Cycles of Stability and Flare-Ups
Chronic airway diseases often follow repeating cycles:
-
Stable colonisation – coexistence with minimal inflammation
-
Disruption – antibiotics, viral infection, or new strain
-
Flare-up – inflammation and tissue damage
-
Partial recovery – new stable community forms
Each cycle leaves the microbial ecosystem slightly altered — selecting for organisms that can survive stress and immune attack.
Evolutionary Summary
| Pressure | Effect on Microbes | Result for Host |
|---|---|---|
| Antibiotics | Resistant, stress-adapted strains | Harder-to-treat infection |
| Nutrient limitation | Toxin and enzyme producers | Tissue damage |
| Immune suppression | Less control of microbes | Opportunistic growth |
| Microbiome loss | Opportunist expansion | Reduced resilience |
| Biofilm evolution | Genetic drift, persistence | Chronic inflammation |
Key Takeaway
Microbes evolve under pressure from antibiotics, immune stress, and competition.
They don’t plan to harm the host — they adapt to survive.
Unfortunately, those same adaptations often make them more damaging and persistent.
This is why good airway care, careful antibiotic use, and microbiome-friendly approaches are essential to keep the system in balance.
👉 Read also: Colonisation vs Infection in Airways Disease
(Learn how to recognise the difference, when treatment is needed, and how to keep microbial balance.)










